Moving to protect a lucrative monopoly against impending competition, Amgen has reached an agreement that will preserve its status as the main supplier of anemia drugs to one of the nation's two large kidney dialysis chains. ... Deal Assures Market for Anemia Drug
Thursday, November 17, 2011
Deal Assures Market for Anemia Drug
Moving to protect a lucrative monopoly against impending competition, Amgen has reached an agreement that will preserve its status as the main supplier of anemia drugs to one of the nation's two large kidney dialysis chains. ... Deal Assures Market for Anemia Drug
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment